Discover your next big idea at PACK EXPO Las Vegas this September
Experience a breakthrough in packaging & processing and transform your business with solutions from 2,300 suppliers spanning all industries.
REGISTER NOW & SAVE

U.S. Faces Shortage of Childhood Cancer Drug

Teva Pharmaceuticals stopped production of vincristine, which is used to treat multiple forms of childhood cancer.

vincristine shortage / Image: Getty
vincristine shortage / Image: Getty

A recent Forbes article discussed the “critical shortage” of vincristine, a drug that treats various forms of childhood cancer including leukemia and lymphoma. Teva Pharmaceuticals and Pfizer were the only two U.S. manufacturers of the drug, until the former ceased production back in July. Now, physicians could be forced to ration the drug putting the thousands of children who rely on the treatment for cancer in danger.

According to a spokesperson at Pfizer, the lone manufacturer of vincristine is working to increase production 3-4 times its normal input to meet demand.

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—<i>Packaging World</i> editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
Annual Outlook Report: Automation & Robotics
What's in store for CPGs in 2025 and beyond? <i>Packaging World</i> editors explore the survey responses from 118 brand owners, CPG, and FMCG <i>Packaging World</i> readers for its new Annual Outlook Report.
Download
Annual Outlook Report: Automation & Robotics